Cardiovascular risk and all-cause mortality across low-density lipoprotein cholesterol levels in seropositive rheumatoid arthritis: a nationwide cohort study
Authors:
- 1 October 2026
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 55 (6) , 393-402
Abstract
No abstract availableFunding Information
- Yuhan Corporation
This publication has 31 references indexed in Scilit:
- Performance of the Predicting Risk of Cardiovascular Disease Events Calculator in Rheumatoid ArthritisArthritis & Rheumatology, 2026
- Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohortsAnnals of the Rheumatic Diseases, 2025
- Association of Cardiovascular Outcomes With Low‐Dose Glucocorticoid Prescription in Patients With Rheumatoid ArthritisArthritis & Rheumatology, 2024
- All-cause and cause-specific mortality in rheumatoid arthritis: a meta-analysisZeitschrift für Rheumatologie, 2024
- Systemic inflammation response index is associated with increased all-cause and cardiovascular mortality in US adults with rheumatoid arthritisPreventive Medicine, 2024
- Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019JACC, 2020
- Co-morbidities in established rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2011
- Resistencia insulínica y artritis reumatoideReumatología Clínica, 2011
- Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta‐analysis of observational studiesArthritis Care & Research, 2008
- Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialThe Lancet, 2004